Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: A large study

Molecular Biology Reports

Volumn 41, Issue 5, 2014, Pages 2989-2997

  Lin, Xian Feng ^a,b   Shi, Ke Qing ^a   You, Jie ^a   Liu, Wen Yue ^a   Luo, Ying Wan ^a   Wu, Fa Ling ^a   Chen, Yong Ping ^a   Wong, Danny Ka Ho ^c,d   Yuen, Man Fung ^c,d   Zheng, Ming Hua ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Colorectal malignant neoplasm; Metabolic syndrome; Neoplasm; Nonalcoholic fatty liver disease; Risk factor

Indexed keywords

ABDOMINAL MASS; ABDOMINAL PAIN; ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; FEMALE; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MELENA; NONALCOHOLIC FATTY LIVER; PREVALENCE; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; RISK FACTOR; SIGMOID; SIGMOID CARCINOMA; WEIGHT REDUCTION; AGED; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; COMPLICATION; METABOLIC SYNDROME X; MIDDLE AGED; RISK;

AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; PREVALENCE; RETROSPECTIVE STUDIES; RISK; RISK FACTORS;

EID: 84905702697     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3157-y     Document Type: Article

References (45)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277-300
2. Sung JJ, Lau JY, Young GP, Sano Y, Chiu HM, Byeon JS, Yeoh KG, Goh KL, Sollano J, Rerknimitr R et al (2008) Asia Pacific consensus recommendations for colorectal cancer screening. Gut 57:1166-1176
3. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137-2150 (Pubitemid 46655601)
4. Ji BT, Devesa SS, Chow WH, Jin F, Gao YT (1998) Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994. Cancer Epidemiol Biomarkers Prev 7:661-666 (Pubitemid 28374595)
5. Lu JB, Sun XB, Dai DX, Zhu SK, Chang QL, Liu SZ, Duan WJ (2003) Epidemiology of gastroenterologic cancer in Henan Province, China. World J Gastroenterol 9:2400-2403
6. Yang L, Parkin DM, Li LD, Chen YD, Bray F (2004) Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer 90:2157-2166 (Pubitemid 38869723)
7. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED et al (2012) Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366:2345-2357
8. Dominic OG, McGarrity T, Dignan M, Lengerich EJ (2009) American college of gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol 104:2626-2627
9. Sung JJ, Choi SY, Chan FK, Ching JY, Lau JT, Griffiths S (2008) Obstacles to colorectal cancer screening in Chinese: a study based on the health belief model. Am J Gastroenterol 103:974-981 (Pubitemid 351501081)
10. Watson AJ, Collins PD (2011) Colon cancer: a civilization disorder. Dig Dis 29:222-228
11. Fujita T (2010) Colorectal cancer. Lancet 376:331
12. Giovannucci E (2002) Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 31:925-943
13. Marchesini G, Forlani G (2002) NASH: from liver diseases to metabolic disorders and back to clinical hepatology. Hepatology 35:497-499 (Pubitemid 34106393)
14. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844-1850 (Pubitemid 33641605)
15. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140:124-131
16. Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR (2006) The metabolic syndrome and risk of incident colorectal cancer. Cancer 107:28-36 (Pubitemid 43941640)
17. Murphy TK, Calle EE, Rodriguez C, Kahn HS, Thun MJ (2000) Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 152:847-854
18. Giovannucci E (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 86:s836-s842
19. Komninou D, Ayonote A, Richie JP Jr, Rigas B (2003) Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med (Maywood) 228:396-405 (Pubitemid 37203647)
20. Siegel AB, Zhu AX (2009) Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer 115:5651-5661
21. Wong VW, Wong GL, Tsang SW, Fan T, Chu WC, Woo J, Chan AW, Choi PC, Chim AM, Lau JY et al (2011) High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut 60:829-836
22. Stadlmayr A, Aigner E, Steger B, Scharinger L, Lederer D, Mayr A, Strasser M, Brunner E, Heuberger A, Hohla F et al (2011) Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. J Intern Med 270:41-49
23. Hwang ST, Cho YK, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI, Won KH, Jin W (2010) Relationship of nonalcoholic fatty liver disease to colorectal adenomatous polyps. J Gastroenterol Hepatol 25:562-567
24. Vandenbroucke JP, Von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M (2009) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Gac Sanit 23:158
25. Obika M, Noguchi H (2012) Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res 2012:145754
26. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J (2005) The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12:295-300
27. Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A (2007) What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol 22:794-800 (Pubitemid 46911036)
28. Wu X, Cokkinides V, Chen VW, Nadel M, Ren Y, Martin J, Ellison GL (2006) Associations of subsite-specific colorectal cancer incidence rates and stage of disease at diagnosis with county-level poverty, by race and sex. Cancer 107:1121-1127 (Pubitemid 44384818)
29. Larsen IK, Bray F (2010) Trends in colorectal cancer incidence in Norway 1962-2006: an interpretation of the temporal patterns by anatomic subsite. Int J Cancer 126:721-732
30. Gluecker TM, Johnson CD, Harmsen WS, Offord KP, Harris AM, Wilson LA, Ahlquist DA (2003) Colorectal cancer screening with CT colonography, colonoscopy, and double-contrast barium enema examination: prospective assessment of patient perceptions and preferences. Radiology 227:378-384 (Pubitemid 36514750)
31. Ioannou GN, Chapko MK, Dominitz JA (2003) Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 98:2082-2091 (Pubitemid 37185810)
32. Marignani M, Angeletti S (2002) Nonalcoholic fatty liver disease. N Engl J Med 347:768-769
33. Williams R (2006) Global challenges in liver disease. Hepatology 44:521-526
34. Giovannucci E (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131:3109S-3120S
35. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J (2004) Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40:46-54 (Pubitemid 38868922)
36. Procaccini C, Galgani M, De Rosa V, Carbone F, La Rocca C, Ranucci G, Iorio R, Matarese G (2010) Leptin: the prototypic adipocytokine and its role in NAFLD. Curr Pharm Des 16:1902-1912
37. Tilg H, Diehl AM (2011) NAFLD and extrahepatic cancers: have a look at the colon. Gut 60:745-746
38. An W, Bai Y, Deng SX, Gao J, Ben QW, Cai QC, Zhang HG, Li ZS (2012) Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis. Eur J Cancer Prev 21:126-133
39. Saxena A, Chumanevich A, Fletcher E, Larsen B, Lattwein K, Kaur K, Fayad R (2012) Adiponectin deficiency: role in chronic inflammation induced colon cancer. Biochim Biophys Acta 1822:527-536
40. Ogunwobi OO, Beales IL (2007) The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt. Int J Colorectal Dis 22:401-409 (Pubitemid 46336244)
41. Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169:1505-1522 (Pubitemid 351181984)
42. Aggarwal BB, Gehlot P (2009) Inflammation and cancer: how friendly is the relationship for cancer patients? Curr Opin Pharmacol 9:351-369
43. Ono M (2008) Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci 99:1501-1506
44. Sonnenberg GE, Krakower GR, Kissebah AH (2004) A novel pathway to the manifestations of metabolic syndrome. Obes Res 12:180-186 (Pubitemid 41132540)
45. Anderson JC, Alpern Z, Sethi G, Messina CR, Martin C, Hubbard PM, Grimson R, Ells PF, Shaw RD (2005) Prevalence and risk of colorectal neoplasia in consumers of alcohol in a screening population. Am J Gastroenterol 100:2049-2055